Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more
Tuesday, January 28, 2014
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) West Coast conference January 28-29 in Burlingame.
read more
Tuesday, January 28, 2014
CPhI Worldwide, organised by UBM Live, announces the launch of the CPhI Pharma InsightsUSA market report. A joint venture with InformEx, the report will provide European perspectives on the accessibility, growth and export market in the USA and is ...
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more
Tuesday, January 28, 2014
SGS, the world’s leading inspection, verification, testing and certification company, announced today its plan
to open its fifth North American Life Science Services laboratory in Carson, California.
read more
Tuesday, January 28, 2014
Almac’s Diagnostics business unit today announced the publication of its breast cancer chemotherapy response assay in the Journal of the National Cancer Institute (JNCI).
read more
Tuesday, January 28, 2014
AAIPharma Services Corp. (“AAIPharma”), a
leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in
pharmaceutical API ...
read more
Tuesday, January 28, 2014
INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of two senior executives to its oncology team. Asli Turkes, PhD has joined ...
read more
Thursday, February 06, 2014
AmSafe Bridport today announced the extended, ongoing contract with Kuehne + Nagel S.a.r.l to deliver precise logistical support for the DuPont™ Tyvek® Air Cargo Thermal Cover, which AmSafe Bridport distributes to its increasing number of European ...
read more
Thursday, February 06, 2014
Almac’s Diagnostics business unit today announced the presentation of an external validation of their ColDx signature for stage II colon cancer recurrence. Following publication of the initial validation study in the Journal of Clinical Oncology (JCO...
read more
Thursday, February 06, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital ...
read more
Thursday, February 06, 2014
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development ...
read more
Friday, February 07, 2014
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, introduced revisions to its PharmaTherm™ line of solutions to pharmaceutical industry professionals today at the 13th Annual Cool Chain ...
read more
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
Friday, February 07, 2014
Dubai, United Arab Emirates, January 27, 2014 - ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets.
read more